Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Feb 2023 for NeuroPace Inc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Michael Favet: trading record in brief
Michael Favet, listed as chief executive, appears in our data through filings on NeuroPace Inc shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 4 June 2021 and the latest from 21 February 2023.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 22 February 2023 came the latest disclosure, a share grant in NeuroPace Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Favet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
225,000 shares0Common StockSEC:0001209191-23-011945:0
155,080 shares0Common StockSEC:0001209191-22-017119:0
27,000 shares0Common StockSEC:0001209191-21-043744:0
26,590 shares0Common StockSEC:0001209191-21-038994:0
4 of 4 declarations
